Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 118
Filter
1.
Data Brief ; 25: 104120, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31304213

ABSTRACT

Globally there is increasing concern about the decline in the health of oak Quercus trees. The impact of a decline in oak trees on associated biodiversity, species that utilize oak trees, is unknown. Here we collate a database of all known birds, bryophytes, fungi, invertebrates, lichens and mammals that use oak (Quercus petraea and Q. robur) in the UK. In total 2300 species are listed in the database. For each species we provide a level of association with oak, ranging from obligate (only found on oak) to cosmopolitan (found on a wide range of other tree species). Data on the ecology of each oak associated species was collated: part of tree used, use made of tree (feeding, roosting, breeding), age of tree, woodland type, tree form (coppice, pollarded, or natural growth form) and season when the tree was used. Data on use or otherwise by each of the 2300 species of 30 other tree species was also collated. A complete list of data sources is provided. For further insights into how this data can be used see Collapsing foundations: The ecology of the British oak, implications of its decline and mitigation options [1]. Data can be found at EIDC https://doi.org/10.5285/22b3d41e-7c35-4c51-9e55-0f47bb845202.

2.
Am Heart J ; 169(4): 579-86.e3, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25819866

ABSTRACT

BACKGROUND: There is a genetic contribution to the risk of ventricular arrhythmias in survivors of acute coronary syndromes (ACS). We wished to explore the role of 33 candidate single nucleotide polymorphisms (SNPs) in prolonged repolarization and sudden death in patients surviving ACS. METHODS: A total of 2,139 patients (1680 white ethnicity) surviving an admission for ACS were enrolled in the prospective Coronary Disease Cohort Study. Extensive clinical, echocardiographic, and neurohormonal data were collected for 12 months, and clinical events were recorded for a median of 5 years. Each SNP was assessed for association with sudden cardiac death (SCD)/cardiac arrest (CA) and prolonged repolarization at 3 time-points: index admission, 1 month, and 12 months postdischarge. RESULTS: One hundred six SCD/CA events occurred during follow-up (6.3%). Three SNPs from 3 genes (rs17779747 [KCNJ2], rs876188 [C14orf64], rs3864180 [GPC5]) were significantly associated with SCD/CA in multivariable models (after correction for multiple testing); the minor allele of rs17779747 with a decreased risk (hazard ratio [HR] 0.68 per copy of the minor allele, 95% CI 0.50-0.92, P = .012), and rs876188 and rs386418 with an increased risk (HR 1.52 [95% CI 1.10-2.09, P = .011] and HR 1.34 [95% CI 1.04-1.82, P = .023], respectively). At 12 months postdischarge, rs10494366 and rs12143842 (NOS1AP) were significant predictors of prolonged repolarization (HR 1.32 [95% CI 1.04-1.67, P = .022] and HR 1.30 [95% CI 1.01-1.66, P = .038], respectively), but not at earlier time-points. CONCLUSION: Three SNPs were associated with SCD/CA. Repolarization time was associated with variation in the NOS1AP gene. This study demonstrates a possible role for SNPs in risk stratification for arrhythmic events after ACS.


Subject(s)
Acute Coronary Syndrome/complications , Arrhythmias, Cardiac/genetics , DNA/genetics , Electrocardiography , Genetic Markers , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide , Acute Coronary Syndrome/genetics , Acute Coronary Syndrome/metabolism , Aged , Arrhythmias, Cardiac/etiology , Arrhythmias, Cardiac/metabolism , Female , Follow-Up Studies , Genotype , Humans , Male , Prospective Studies , Risk Factors
3.
J Hum Hypertens ; 27(4): 237-44, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22739771

ABSTRACT

This study examined renin-angiotensin-aldosterone (RAAS) system gene variants for associations with cardiovascular risk factors and outcomes in coronary heart disease. Coronary disease patients (n=1186) were genotyped for 21 single-nucleotide polymorphisms (SNPs) within angiotensinogen (AGT), angiotensin-converting enzyme (ACE), angiotensin-II type-1 receptor (AGTR1) and aldosterone synthase (CYP11B2). Associations with all-cause mortality and cardiovascular readmissions were assessed over a median of 3.0 years. The AGT M235T 'T' allele was associated with a younger age of clinical coronary disease onset (P=0.006), and the AGT rs2478545 minor allele was associated with lower circulating natriuretic peptides (P=0.0001-P=0.001) and E/E(1) (P=0.018). Minor alleles of AGT SNPs rs1926723 and rs11122576 were associated with more frequent history of renal disease (P0.04) and type-2 diabetes (P0.02), higher body mass index (P0.02) and greater mortality (P0.007). AGT rs11568054 minor allele carriers had more frequent history of renal disease (P=0.04) and higher plasma creatinine (P=0.033). AGT rs6687360 minor allele carriers exhibited worse survival (P=0.02). ACE rs4267385 was associated with older clinical coronary disease onset (P=0.008) and hypertension (P=0.013) onset, increased plasma creatinine (P=0.01), yet greater mortality (P=0.044). Less history of hypertension was observed with the AGTR1 rs12685977 minor allele (P=0.039). Genetic variation within the RAAS was associated with cardiovascular risk factors and accordingly poorer survival.


Subject(s)
Coronary Artery Disease/genetics , Coronary Artery Disease/mortality , Polymorphism, Single Nucleotide , Renin-Angiotensin System/genetics , Age of Onset , Aged , Angiotensinogen/genetics , Comorbidity , Coronary Artery Disease/ethnology , Cytochrome P-450 CYP11B2/genetics , Female , Gene Frequency , Genetic Predisposition to Disease , Humans , Hypertension/genetics , Hypertension/mortality , Kaplan-Meier Estimate , Linear Models , Male , Middle Aged , New Zealand/epidemiology , Odds Ratio , Peptidyl-Dipeptidase A/genetics , Phenotype , Prognosis , Proportional Hazards Models , Receptor, Angiotensin, Type 1/genetics , Risk Assessment , Risk Factors , Time Factors
4.
J R Army Med Corps ; 155(1): 34-7, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19817088

ABSTRACT

Tropical diseases remain a significant threat to deployed military personnel as demonstrated by recent outbreaks amongst troops in Sierra Leone, Iraq and Afghanistan. Five cases are presented from military deployments in tropical or sub-tropical areas, which illustrate important diseases and diagnostic principles for military physicians.


Subject(s)
Military Personnel , Tropical Medicine , Adult , Afghanistan , Dengue/diagnosis , Diagnosis, Differential , Female , Fever of Unknown Origin/etiology , Hepatitis, Viral, Human/diagnosis , Humans , Iraq , Male , Middle Aged , Myiasis/diagnosis , Sarcoidosis/diagnosis , Sierra Leone , United Kingdom
6.
Intern Med J ; 36(10): 643-7, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16958641

ABSTRACT

BACKGROUND: Accurate perceptions of future cardiac risk are important to ensure informed treatment choices and lifestyle adaptation in patients following myocardial infarction (MI). The aim of this study was to investigate whether risk perceptions of patients with MI were accurate compared with an established clinical risk model. METHODS: Seventy-nine consecutive patients with acute MI admitted to the Coronary Care Unit, Auckland Hospital, completed a questionnaire assessing risk perceptions. Clinical data were used to calculate patients' Thrombolysis In Myocardial Infarction (TIMI) risk scores, a validated predictive model of prognosis. The main outcome measures were the associations between perceived risk, TIMI risk scores and troponin T. RESULTS: Patients' risk perceptions showed no correlation with thrombolysis in myocardial infarction risk scores (r = -0.06; P = 0.61) or with troponin T (r = -0.07; P = 0.53). Patients' risk perceptions were not significantly associated with age or sex, and were not significantly higher in those who had experienced a previous MI, a family history of coronary heart disease, diabetes or smokers. Higher perceived risk was significantly associated with a number of illness perceptions, including worse consequences of the MI and lower beliefs in the benefit of treatment. Patients who overestimated their risk were more anxious than other patients (F(2, 73) = 22.97; P = 0.0001). CONCLUSION: Patients with MI ideas about their personal risk of future MI are not congruent with their clinical risk assessments. Inpatient hospital care appears to be unsuccessful in communicating prognosis effectively to patients. Improving the accuracy of risk perceptions may help decrease unnecessary cardiac anxiety and invalidism in some patients and prompt risk-reducing behaviours in others.


Subject(s)
Comprehension , Myocardial Infarction/epidemiology , Myocardial Infarction/psychology , Perception , Aged , Coronary Care Units/trends , Female , Forecasting , Humans , Male , Middle Aged , Myocardial Infarction/therapy , Risk Assessment , Risk Reduction Behavior , Surveys and Questionnaires , Thrombolytic Therapy/trends
7.
New Phytol ; 168(2): 423-34, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16219081

ABSTRACT

Nitrogen translocation was measured in Cladonia portentosa during 2 yr growth in Scottish heathland. Translocation was predicted to occur if N is resorbed from senescent basal tissue and recycled within the thallus. (15)N was introduced into either the lower (TU thalli) or upper (TD thalli) 25 mm of 50-mm-long thalli as (15)N-NH(4) (+), (15)N-NO(3) (-) or (15)N-glycine. Labelled thalli were placed within intact lichen cushions, either upright (TU) or inverted (TD). Vertical distribution of label was quantified immediately following labelling and after 1 and 2 yr. Independently of the form of introduced label, (15)N migrated upwards in TU thalli, with new growth being a strong sink. Sink regions for (15)N during year 1 (including new growth) became sources of (15)N translocated to new growth in year 2. Upward migration into inverted bases was minimal in TD thalli, but was again marked in new growth that developed from inverted apices. Relocation of N to regions of growth could facilitate internal N recycling, a process postulated to explain the ecological success of mat-forming lichens.


Subject(s)
Ascomycota/growth & development , Ascomycota/metabolism , Lichens/growth & development , Lichens/metabolism , Nitrogen/metabolism , Biological Transport, Active , Ecosystem , Kinetics , Models, Biological , Nitrogen Isotopes , Scotland
10.
Trans R Soc Trop Med Hyg ; 97(5): 550, 2003.
Article in English | MEDLINE | ID: mdl-15307423

ABSTRACT

Residents of the UK returning from northern Pakistan with Plasmodium vivax infection tend to develop symptoms and present to hospital in the summer months, irrespective of the month of return. Thus, infections acquired in the cooler months of November to April appear to have a longer latency before presentation. Experiments suggest that more hypnozoites arise from the liver when ambient temperatures fall, somehow 'programming' parasites within biting mosquitoes.


Subject(s)
Malaria, Vivax/ethnology , Seasons , Travel , England/epidemiology , Humans , Pakistan/ethnology
13.
Catheter Cardiovasc Interv ; 50(4): 377-81; discussion 382-3, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10931603

ABSTRACT

This randomized trial compared a strategy of direct stenting without predilatation (n = 39) with conventional stenting with predilatation (n = 42) in patients with suitable lesions in native vessels > or = 2. 5-mm diameter to be covered by either a 9- or 16-mm-length NIR Primo stent. Equipment cost [mean (median) +/- SD] was less in those with direct stenting [$1,199 (979) +/- 526] than in those with predilatation [$1,455 (1,285) +/- 401, P < 0.001]. There was no significant difference in contrast use or fluoroscopy time. Procedural time was shorter in the direct stenting group. The clinical outcome at 1 month was satisfactory in both groups. In selected patients, a strategy of direct stenting is feasible, costs less, and is quicker to perform than the conventional strategy of stenting following predilatation.


Subject(s)
Angina Pectoris/therapy , Angioplasty, Balloon, Coronary/instrumentation , Stents , Adult , Aged , Angina Pectoris/diagnostic imaging , Angioplasty, Balloon, Coronary/economics , Australia , Coronary Angiography , Costs and Cost Analysis , Female , Humans , Male , Middle Aged , New Zealand , Stents/economics
14.
N Z Med J ; 113(1109): 158-61, 2000 May 12.
Article in English | MEDLINE | ID: mdl-10894341

ABSTRACT

AIM: To audit Phase II cardiac rehabilitation services available to patients admitted to Auckland Hospital in order to assess patient uptake and to identify problems with patient recruitment to the service. METHODS: We performed a retrospective review from 1/8/ 97 to 30/9/97 of all patients admitted to the coronary care/ cardiology departments in Auckland Hospital. RESULTS: There were 289 patient admissions in this two month period, of which 22 (8%) were readmissions. 154 (54%) were admissions with provisional diagnoses of chest pain, of whom eight were readmissions. A total of 113 (39%) patients were felt to be suitable for the rehabilitation programme, of whom 50 (44%) attended one or more sessions and 22 (19%) completed the six week programme. 63 (56%) of the eligible patients did not attend any session. Reasons for non-attendance included the distance to be travelled, availability of transport and problems associated with taking time off work. A major finding of the audit was that the systems currently in place to follow patients are inadequate to allow formal audit and evaluation of the rehabilitation service. CONCLUSIONS: Although a reasonable rehabilitation service exists for Auckland Hospital patients, less than half of suitable patients attend a single session. There is a need for better collection and recording of patient data in order to facilitate the development of evaluation and audit tools.


Subject(s)
Coronary Care Units/statistics & numerical data , Coronary Disease/rehabilitation , Medical Audit , Patient Admission/statistics & numerical data , Aged , Aged, 80 and over , Ambulatory Care/statistics & numerical data , Cohort Studies , Coronary Disease/epidemiology , Female , Humans , Male , Middle Aged , New Zealand , Patient Dropouts/statistics & numerical data , Patient Readmission/statistics & numerical data
15.
BMJ ; 320(7248): 1502-4, 2000 Jun 03.
Article in English | MEDLINE | ID: mdl-10834890

ABSTRACT

OBJECTIVE: To assess whether a raised serum troponin T concentration would be an independent predictor of death in patients with an acute ischaemic stroke. DESIGN: Observational study. SETTING: Auckland Hospital, Auckland, New Zealand. SUBJECTS: All 181 patients with an acute ischaemic stroke admitted over nine months in 1997-8, from a total of 8057 patients admitted to the acute medical service. MAIN OUTCOME MEASURES: Blood samples for measuring troponin T concentration were collected 12-72 hours after admission; other variables previously associated with severity of stroke were also recorded and assessed as independent predictors of inpatient mortality. RESULTS: Troponin T concentration was raised (>0.1 microgram/l) in 17% (30) of patients admitted with an acute ischaemic stroke. Thirty one patients died in hospital (12/30 (40%) patients with a raised troponin T concentration v 19/151 (13%) patients with a normal concentration (relative risk 3.2 (95% confidence 1.7 to 5. 8; P=0.0025)). Of 17 possible predictors of death, assessed in a multivariate stepwise model, only a raised troponin T concentration (P=0.0002), age (P=0.0008), and an altered level of consciousness at presentation (P=0.0074) independently predicted an adverse outcome. CONCLUSIONS: Serum troponin T concentration at hospital admission is a powerful predictor of mortality in patients admitted with an acute ischaemic stroke.


Subject(s)
Stroke/blood , Troponin T/blood , Acute Disease , Aged , Biomarkers/blood , Female , Humans , Male , New Zealand/epidemiology , Stroke/mortality , Survival Analysis
17.
J Am Coll Cardiol ; 35(6): 1516-24, 2000 May.
Article in English | MEDLINE | ID: mdl-10807455

ABSTRACT

OBJECTIVES: To evaluate the corrected Thrombolysis in Myocardial Infarction (TIMI) frame count (CTFC) as a predictor of late survival after myocardial infarction. BACKGROUND: Thrombolysis in Myocardial Infarction flow grades predict late survival after myocardial infarction. The CTFC provides a more reproducible measurement of infarct-related artery blood flow than the TIMI flow grade, and has been linked to 30-day outcomes, but it has not yet been established how the CTFC correlates with late survival. METHODS: Of 1,001 patients with acute myocardial infarction presenting within 4 h of symptom onset, 882 underwent angiography at approximately three weeks. Infarct artery flow was assessed, blinded to clinical outcomes, according to the CTFC and TIMI flow grade. Late cardiac mortality and survival were determined in 97.5% of patients. RESULTS: The mean CTFC was 40 +/- 29 in 644 patent infarct arteries (median, 34 [interquartile range, 24 to 47]). The CTFC, assessed as a continuous univariate variable, was found to be a predictor of five-year survival, as was the TIMI flow grade (both p < 0.001). On multivariate analysis, factors associated with five-year survival included the ejection fraction or end-systolic volume index (both p < 0.001); exercise duration (p = 0.005), age (p = 0.008), diabetes (p = 0.02) and CTFC (p = 0.02) or TIMI flow (p = 0.02). The same factors, except for the CTFC and TIMI flow grade, were predictors of 10-year survival. CONCLUSIONS: The CTFC three weeks after myocardial infarction was an independent predictor of five-year survival, but not 10-year survival. Although the CTFC provided additional prognostic information within TIMI flow grades, its superiority was not demonstrated.


Subject(s)
Myocardial Infarction/drug therapy , Thrombolytic Therapy , Adult , Aged , Blood Flow Velocity/drug effects , Coronary Angiography/drug effects , Coronary Circulation/drug effects , Female , Follow-Up Studies , Humans , Male , Middle Aged , Myocardial Infarction/mortality , Randomized Controlled Trials as Topic , Streptokinase/administration & dosage , Survival Rate , Tissue Plasminogen Activator/administration & dosage , Treatment Outcome
20.
Aust N Z J Med ; 28(4): 518-24, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9777132

ABSTRACT

The Fibrinolytic Therapy Trialists' Collaborative Group has demonstrated that patients without clear contraindications who present with ischaemic chest pain within 12 hours of the onset of symptoms and who have ST segment elevation or bundle branch block on their electrocardiogram (ECG), will benefit from thrombolytic therapy. Therefore the treatment of patients presenting with ischaemic chest pain is guided by the initial ECG. This paper addresses the question of thrombolytic eligibility in several subsets of patients who may benefit from treatment. It also explores the data which confirm the benefit for patients presenting with an inferior myocardial infarction and for those presenting from six-12 hours after the onset of symptoms. In conclusion, thrombolytic therapy should not be routinely withheld from diabetic or elderly patients, menstruating women and patients who have had cardiopulmonary resuscitation.


Subject(s)
Myocardial Infarction/drug therapy , Thrombolytic Therapy , Age Factors , Aged , Cardiopulmonary Resuscitation , Diabetic Retinopathy/complications , Electrocardiography , Female , Humans , Male , Menstruation , Middle Aged , Myocardial Infarction/therapy , Patient Selection , Randomized Controlled Trials as Topic , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...